Merck KGaA (MKGAF)
164.58
+0.58
(+0.35%)
USD |
OTCM |
Aug 26, 16:00
Merck Net Income (Quarterly) : 574.38M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 574.38M |
| March 31, 2026 | 782.68M |
| December 31, 2025 | 377.11M |
| September 30, 2025 | 1.049B |
| June 30, 2025 | 742.41M |
| March 31, 2025 | 776.72M |
| December 31, 2024 | 713.62M |
| September 30, 2024 | 892.02M |
| June 30, 2024 | 651.31M |
| March 31, 2024 | 758.66M |
| December 31, 2023 | 632.35M |
| September 30, 2023 | 805.00M |
| June 30, 2023 | 768.37M |
| March 31, 2023 | 858.35M |
| December 31, 2022 | 671.79M |
| September 30, 2022 | 932.22M |
| June 30, 2022 | 925.90M |
| March 31, 2022 | 991.70M |
| December 31, 2021 | 922.41M |
| September 30, 2021 | 900.54M |
| June 30, 2021 | 900.60M |
| March 31, 2021 | 900.96M |
| December 31, 2020 | 525.76M |
| September 30, 2020 | 942.05M |
| June 30, 2020 | 318.27M |
| Date | Value |
|---|---|
| March 31, 2020 | 504.57M |
| December 31, 2019 | 373.11M |
| September 30, 2019 | 376.91M |
| June 30, 2019 | 473.06M |
| March 31, 2019 | 225.96M |
| December 31, 2018 | 219.77M |
| September 30, 2018 | 375.69M |
| June 30, 2018 | 290.57M |
| March 31, 2018 | 409.26M |
| December 31, 2017 | 1.214B |
| September 30, 2017 | 727.68M |
| June 30, 2017 | 453.39M |
| March 31, 2017 | 557.42M |
| December 31, 2016 | 285.58M |
| September 30, 2016 | 513.41M |
| June 30, 2016 | 354.55M |
| March 31, 2016 | 653.79M |
| December 31, 2015 | 133.31M |
| September 30, 2015 | 406.48M |
| June 30, 2015 | 382.43M |
| March 31, 2015 | 320.73M |
| December 31, 2014 | 352.01M |
| September 30, 2014 | 330.84M |
| June 30, 2014 | 419.64M |
| March 31, 2014 | 448.59M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| STRATEC SE | 4.839M |
| Sartorius AG | 107.78M |
| Petros Pharmaceuticals, Inc. | -0.9556M |
| Danaher Corp. | 870.00M |
| Illumina, Inc. | 207.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.318B |
| Total Expenses (Quarterly) | 5.748B |
| EPS Diluted (Quarterly) | 1.310 |
| Enterprise Value | 83.52B |
| Gross Profit Margin (Quarterly) | 58.26% |
| Profit Margin (Quarterly) | 9.09% |
| Earnings Yield | 3.87% |
| Operating Earnings Yield | 6.78% |
| Normalized Earnings Yield | 4.558 |